Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 73.55

-0.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SemiBull who wrote (3179)	12/17/2001 9:31:47 AM
From: SemiBull	Read Replies (1) of 4676

8:28AM ISIS Pharm (ISIP) 21.84: Co's GeneTrove division has initiated a target validation collaboration with Chiron (CHIR). In the partnership, Chiron gains access to Isis' expertise in the application of antisense technology as a tool for gene functionalization and target validation and a license to specific patents within Isis' functional genomics suite of patents. Specific financial terms were not disclosed. finance.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next